20.600
+0,00%
2026-10-19
Fundamental Analysis
37 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -104.3% | +37.9% | 2 / 3 | -18.1% | -19.47 pp | -21.76 pp | +15.7% | 0.28 | 8.39 | 39,9 | −18,1% | −0,4 | −104,3% | 8.39 | 10.02 | −16,3% |
| Pts | 0 | 8 | 8 | 0 | 0 | 0 | 4 | 12 | 8 | |||||||
Valuation annotation:Price: 20.600 (close price on 2026-10-19)EPS (TTM): 2.456
Financial charts
1.Revenue & growth
VND bn39,9Q2/26
1.Revenue & growth
VND bn39,9Q2/26
2.Profit & growth
VND bn-0,44Q2/26
3.Profit mix (Penman)
VND bn178Q2/26
4.Margins & cost structure
%67.2%Q2/26
5.Returns & cash cycle
% · days14.9%Q2/26
6.Earnings quality & cash
VND bn240Q2/26
7.Asset structure
VND bn1.351Q2/26
8.Funding & debt health
VND bn · times1.351Q2/26
9.Revenue backlog
VND bn0,85Q2/26
10.Valuation
times · %8,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-7Q2/26
Adjusted EPS growth, latest quarter
-104%
Average adjusted EPS growth, 3 quarters
29.8%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26